Compounded peptide therapy is generally an out-of-pocket service and is not typically covered by insurance
Dose and route discussion belongs to the community sources covered later, not to any validated human protocol
Peptides like BPC-157 and KPV are generally well-tolerated, but sourcing from a reputable compounding pharmacy is crucial to ensure purity and effectiveness
Oocyte-derived E-cadherin acts as a multiple functional factor maintaining the primordial follicle pool in mice
doi:10.1002/jssc.200700404 Metcalfe CD, Chu S, Judt C et al (2010) Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed
Eric Topol of Scripps Research Translational Institute was more direct: "These peptides have no data to support their safety and efficacy." The clinical proponents argue that the FDA's safety concerns immunogenicity risk, impurity risk, organ toxicity are theoretically valid but speculative in practice